116 related articles for article (PubMed ID: 16787769)
1. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
Tsochatzis E; Papatheodoridis GV; Elefsiniotis I; Thanelas S; Theodossiades G; Moulakakis A; Archimandritis AJ
Dig Liver Dis; 2007 May; 39(5):490-4. PubMed ID: 16787769
[TBL] [Abstract][Full Text] [Related]
2. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
4. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
6. Use of recombinant factor VIIa in the perioperative period.
Levi M
Hamostaseologie; 2009 Jan; 29(1):68-70. PubMed ID: 19151850
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
8. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
9. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
Pavese P; Bonadona A; Beaubien J; Labrecque P; Pernod G; Letoublon C; Barnoud D
Can J Anaesth; 2005 Jan; 52(1):26-9. PubMed ID: 15625252
[TBL] [Abstract][Full Text] [Related]
10. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven).
Ali ZS; Al-Shaalan H; Jorgensen J
Blood Coagul Fibrinolysis; 2006 Jun; 17(4):327-9. PubMed ID: 16651879
[TBL] [Abstract][Full Text] [Related]
12. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?].
Skalski JH; Czapla J; Nadziakiewicz P; Kaczmarski J; Zembala M
Przegl Lek; 2002; 59(11):941-5. PubMed ID: 12715727
[TBL] [Abstract][Full Text] [Related]
13. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.
Giangrande PL; Wilde JT; Madan B; Ludlam CA; Tuddenham EG; Goddard NJ; Dolan G; Ingerslev J
Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
Atkison PR; Jardine L; Williams S; Barr RM; Quan D; Wall W
Transplant Proc; 2005 Mar; 37(2):1091-3. PubMed ID: 15848632
[TBL] [Abstract][Full Text] [Related]
15. Benefits of recombinant activated factor VII in complicated liver transplantation.
Gala B; Quintela J; Aguirrezabalaga J; Fernández C; Fraguela J; Suárez F; Gómez M
Transplant Proc; 2005 Nov; 37(9):3919-21. PubMed ID: 16386584
[TBL] [Abstract][Full Text] [Related]
16. The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
Wahlgren CM; Swedenborg J
Eur J Vasc Endovasc Surg; 2003 Aug; 26(2):221-2. PubMed ID: 12917843
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients.
Mathijssen NC; Masereeuw R; Verbeek K; Lavergne JM; Costa JM; van Heerde WL; Nováková IR
Br J Haematol; 2004 May; 125(4):494-9. PubMed ID: 15142120
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients.
Hardy JF; Bélisle S; Van der Linden P
Curr Opin Anaesthesiol; 2009 Feb; 22(1):95-9. PubMed ID: 19295298
[TBL] [Abstract][Full Text] [Related]
19. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients.
Felfernig M; Huepfl M
Clin Neurol Neurosurg; 2008 Mar; 110(3):227-32. PubMed ID: 18083302
[TBL] [Abstract][Full Text] [Related]
20. Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial.
Shao YF; Yang JM; Chau GY; Sirivatanauksorn Y; Zhong SX; Erhardtsen E; Nivatvongs S; Lee PH
Am J Surg; 2006 Feb; 191(2):245-9. PubMed ID: 16442954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
